NAGE Competitors & Alternatives
Compare Niagen Bioscience, Inc. with similar stocks in the same industry
Biotechnology
NAGE
Main Stock$3.53
Tradestie Score
47
Market Cap
$629.25M
P/E Ratio
16.2
Revenue Growth
0.0%
Analyst Upside
+251.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.07
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.15
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.92
|
$293.03M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$12.56
|
$281.75M | 10.4 | 63 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.58
|
$275.54M | - | 43 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.84
|
$275.13M | - | 48 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$21.41
|
$269.08M | - | 56 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.52
|
$262.67M | - | 51 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$32.87
|
$256.54M | - | 58 | Compare |
More NAGE Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2833)
231 stocks in this industry